Coherus Oncology, Inc. (CHRS)
1.07
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.075
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Free Cash Flow : -186.03M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -186.03M |
| March 31, 2026 | -170.57M |
| December 31, 2025 | -138.51M |
| September 30, 2025 | -90.19M |
| June 30, 2025 | -105.87M |
| March 31, 2025 | 0.50M |
| December 31, 2024 | -20.44M |
| September 30, 2024 | -62.02M |
| June 30, 2024 | -54.30M |
| March 31, 2024 | -153.05M |
| December 31, 2023 | -175.17M |
| September 30, 2023 | -262.24M |
| June 30, 2023 | -245.48M |
| March 31, 2023 | -257.39M |
| December 31, 2022 | -243.16M |
| September 30, 2022 | -195.91M |
| June 30, 2022 | -144.92M |
| March 31, 2022 | -94.60M |
| December 31, 2021 | -38.72M |
| September 30, 2021 | 46.24M |
| June 30, 2021 | 78.03M |
| March 31, 2021 | 136.44M |
| December 31, 2020 | 146.91M |
| September 30, 2020 | 132.06M |
| Date | Value |
|---|---|
| June 30, 2020 | 140.86M |
| March 31, 2020 | 95.54M |
| December 31, 2019 | 26.53M |
| September 30, 2019 | -38.37M |
| June 30, 2019 | -135.68M |
| March 31, 2019 | -183.71M |
| December 31, 2018 | -160.06M |
| September 30, 2018 | -142.51M |
| June 30, 2018 | -142.56M |
| March 31, 2018 | -163.56M |
| December 31, 2017 | -204.86M |
| September 30, 2017 | -265.29M |
| June 30, 2017 | -284.41M |
| March 31, 2017 | -255.56M |
| December 31, 2016 | -259.06M |
| September 30, 2016 | -164.48M |
| June 30, 2016 | -164.08M |
| March 31, 2016 | -158.24M |
| December 31, 2015 | -114.15M |
| September 30, 2015 | -152.05M |
| June 30, 2015 | -95.97M |
| March 31, 2015 | -75.64M |
| December 31, 2014 | -26.78M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Enanta Pharmaceuticals, Inc. | -36.94M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -62.09M |
| Cash from Investing (Quarterly) | 29.63M |
| Cash from Financing (Quarterly) | 0.144M |
| Free Cash Flow Per Share (Quarterly) | -0.4011 |
| Free Cash Flow to Equity (Quarterly) | -61.90M |
| Free Cash Flow to Firm (Quarterly) | -59.77M |
| Free Cash Flow Yield | -131.8% |